Harvard Bioscience Acquires Panlab S.l. Establishing A Spanish Subsidiary And Expanding Access In The Neuroscience Research Market
Oct 20th 2007Drug InformationNeurology / Neuroscience
Harvard Bioscience, Inc. (Nasdaq: HBIO), has announced they have completed the purchase of Panlab s.l. of Barcelona Spain for approximately $5.0 million in cash. Panlab distributes, manufactures and develops products and software for life science researchers primarily in the neuroscience research market.”With the acquisition of Panlab, we are able to expand our distribution channels by establishing a subsidiary in Spain. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
